Prevention of human diabetic ketoacidosis by somatostatin. Evidence for an essential role of glucagon.

To evaluate the role of glucagon in the pathogenesis of diabetic ketoacidosis in man, we studied the effect of suppression of glucagon secretion by somatostatin on changes in plasma beta-hydroxybutyrate and glucose concentrations (as well as changes in their precursors) after acute withdrawal of insulin from seven patients with juvenile-type diabetes. Suppression of glucagon secretion prevented the development of ketoacidosis for 18 hours after acute insulin withdrawal, whereas in control studies mild ketoacidosis occurred 10 hours after insulin was stopped. Plasma beta-hydroxybutyrate, glucose, free fatty acid, and glycerol levels were all markedly lower during suppression of glucagon secretion (p smaller than 0.001), whereas plasma alanine levels were higher (p smaller than 0.001). These studies indicate that insulin lack per se does not lead to fulminant diabetic ketoacidosis in man and that glucagon, by means of its gluconeogenic, ketogenic, and lipolytic actions, is a prerequisite to the development of this condition.

[1]  E. Tsalikian,et al.  Plasma glucagon and alanine responses to acute insulin deficiency in man. , 1975, The Journal of clinical endocrinology and metabolism.

[2]  R. Guillemin,et al.  Effects of somatostatin on plasma glucose and glucagon levels in human diabetes mellitus. Pathophysiologic and therapeutic implications. , 1974, The New England journal of medicine.

[3]  N. Ruderman,et al.  The formation of glutamine and alanine in skeletal muscle. , 1974, The Journal of biological chemistry.

[4]  C. J. Goodner,et al.  Somatostatin: Hypothalamic Inhibitor of the Endocrine Pancreas , 1974, Science.

[5]  S. B. Lewis,et al.  Effects of glucagon on lipolysis and ketogenesis in normal and diabetic men. , 1974, The Journal of clinical investigation.

[6]  R. Guillemin,et al.  Inhibition of growth hormone release in humans by somatostatin. , 1973, The Journal of clinical endocrinology and metabolism.

[7]  W. A. Müller,et al.  Hyperglucagonemia in diabetic ketoacidosis. Its prevalence and significance. , 1973, The American journal of medicine.

[8]  E. Cerasi,et al.  Splanchnic and peripheral glucose and amino acid metabolism in diabetes mellitus. , 1972, The Journal of clinical investigation.

[9]  J. Gerich,et al.  Clinical and Metabolic Characteristics of Hyperosmolar Nonketotic Coma , 1971, Diabetes.

[10]  P. Felig,et al.  Glucose and lipid homeostasis in the absence of human growth hormone. , 1971, The Journal of clinical investigation.

[11]  R. Unger,et al.  Glucagon levels and metabolic effects in fasting man. , 1970, The Journal of clinical investigation.

[12]  P. Felig,et al.  Plasma Amino Acid Levels in Diabetic Ketoacidosis , 1970, Diabetes.

[13]  P. Cryer,et al.  Diabetic Ketosis: Serial Plasma Growth Hormone Concentrations During Therapy , 1970, Diabetes.

[14]  W. A. Müller,et al.  Studies of pancreatic alpha cell function in normal and diabetic subjects. , 1970, The Journal of clinical investigation.

[15]  T. B. Miller,et al.  The hormonal control of hepatic gluconeogenesis. , 1970, Recent progress in hormone research.

[16]  M. Heimberg,et al.  The effects of glucagon, dibutyryl cyclic adenosine 3',5'-monophosphate, and concentration of free fatty acid on hepatic lipid metabolism. , 1969, The Journal of biological chemistry.

[17]  J. Nabarro,et al.  Plasma 11-Hydroxycorticosteroid and Growth Hormone Levels in Acute Medical Illnesses , 1969, British medical journal.

[18]  J. Earll,et al.  Remarkable Sensitivity to Insulin in a Patient with Hypopituitarism and Diabetic Acidosis , 1968, Diabetes.

[19]  C. Ezrin,et al.  Metabolic effects of glucagon in human subjects. , 1960, Metabolism: clinical and experimental.

[20]  Scow Ro,et al.  Hormonal control of protein and fat metabolism in the pancreatectomized rat. , 1960 .

[21]  C. Laurell,et al.  Quantitative determination of the glucoprotein pattern of normal serum after electrophoretic separation on filter paper. , 1956, Scandinavian journal of clinical and laboratory investigation.

[22]  P. Bondy,et al.  STUDIES OF THE ROLE OF THE LIVER IN HUMAN CARBOHYDRATE METABOLISM BY THE VENOUS CATHETER TECHNIC. II. PATIENTS WITH DIABETIC KETOSIS, BEFORE AND AFTER THE ADMINISTRATION OF INSULIN. , 1949, The Journal of clinical investigation.